《感染》特刊第二版引言
Introduction to the Special Issue on Infection, Second Edition.
作者信息
Granata Guido
机构信息
Clinical and Research Department for Infectious Diseases, National Institute for Infectious Diseases L. Spallanzani, IRCCS, 00149 Rome, Italy.
出版信息
Antibiotics (Basel). 2024 Jun 29;13(7):607. doi: 10.3390/antibiotics13070607.
Abstract
(CD) is a Gram-positive, anaerobic bacterium that is one of the most common causes of infective diarrhoea worldwide [...].
摘要
艰难梭菌是一种革兰氏阳性厌氧菌，是全球感染性腹泻最常见的病因之一[...]。
相似文献
1
Introduction to the Special Issue on Infection, Second Edition.《感染》特刊第二版引言
Antibiotics (Basel). 2024 Jun 29;13(7):607. doi: 10.3390/antibiotics13070607.
2
Introduction to the Special Issue on .关于……的特刊引言
Antibiotics (Basel). 2021 Oct 11;10(10):1233. doi: 10.3390/antibiotics10101233.
3
spore: coat assembly and formation.孢子：外壳的组装与形成。
Emerg Microbes Infect. 2022 Dec;11(1):2340-2349. doi: 10.1080/22221751.2022.2119168.
4
Comparative Genomics of Clostridioides difficile.艰难梭菌的比较基因组学。
Adv Exp Med Biol. 2024;1435:199-218. doi: 10.1007/978-3-031-42108-2_10.
5
Crystal structure of the sliding DNA clamp from the Gram-positive anaerobic bacterium Clostridioides difficile.革兰氏阳性厌氧菌艰难梭菌滑动DNA夹钳的晶体结构。
J Biochem. 2022 Dec 27;173(1):13-20. doi: 10.1093/jb/mvac079.
6
Clostridioides (Clostridium) difficile in adults with diarrhoea in Vietnam.越南成人腹泻患者中的艰难梭菌（梭状芽孢杆菌）。
Anaerobe. 2023 Jun;81:102741. doi: 10.1016/j.anaerobe.2023.102741. Epub 2023 May 25.
7
Impact of environmental conditions and gut microbiota on the in vitro germination and growth of Clostridioides difficile.环境条件和肠道微生物群对艰难梭菌体外发芽和生长的影响。
FEMS Microbiol Lett. 2022 Oct 29;369(1). doi: 10.1093/femsle/fnac087.
8
Characterizing the flavodoxin landscape in .阐明. 中的黄素蛋白景观
Microbiol Spectr. 2024 Mar 5;12(3):e0189523. doi: 10.1128/spectrum.01895-23. Epub 2024 Feb 6.
9
The Hospital Environment as a Potential Source for Transmission Based on Spore Detection Surveys Conducted at Paediatric Oncology and Gastroenterology Units.基于儿科肿瘤学和胃肠病学单位进行的孢子检测调查，医院环境作为潜在传播源。
Int J Environ Res Public Health. 2023 Jan 15;20(2):1590. doi: 10.3390/ijerph20021590.
10
Advances in Therapeutic Strategies for the Management of Infection.感染管理治疗策略的进展
J Clin Med. 2024 Feb 26;13(5):1331. doi: 10.3390/jcm13051331.
本文引用的文献
1
COVID-19 and Coinfection Analysis in the Intensive Care Unit.重症监护病房中的新型冠状病毒肺炎及合并感染分析
Antibiotics (Basel). 2024 Apr 17;13(4):367. doi: 10.3390/antibiotics13040367.
2
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染：历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
3
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).2018 - 2019年欧洲艰难梭菌当前监测实践、管理指南、治疗途径及检测异质性调查：欧洲艰难梭菌感染抗菌耐药性研究（COMBACTE - CDI）结果
J Hosp Infect. 2023 Jan;131:213-220. doi: 10.1016/j.jhin.2022.11.011. Epub 2022 Dec 1.
4
Bezlotoxumab in Patients with a Primary Infection: A Literature Review.贝佐妥昔单抗用于原发性感染患者：文献综述
Antibiotics (Basel). 2022 Oct 28;11(11):1495. doi: 10.3390/antibiotics11111495.
5
Fidaxomicin for the Treatment of Infection in Adult Patients: An Update on Results from Randomized Controlled Trials.非达霉素用于治疗成年患者感染：随机对照试验结果的最新进展
Antibiotics (Basel). 2022 Oct 6;11(10):1365. doi: 10.3390/antibiotics11101365.
6
Clinical Determinants Predicting Infection among Patients with Chronic Kidney Disease.预测慢性肾病患者感染的临床决定因素
Antibiotics (Basel). 2022 Jun 8;11(6):785. doi: 10.3390/antibiotics11060785.
7
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.艰难梭菌毒素：作用机制与抗毒素治疗学。
Nat Rev Microbiol. 2022 May;20(5):285-298. doi: 10.1038/s41579-021-00660-2. Epub 2021 Nov 26.
8
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.欧洲临床微生物学和传染病学会：成人艰难梭菌感染治疗指南的 2021 年更新。
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21. doi: 10.1016/j.cmi.2021.09.038. Epub 2021 Oct 20.
9
High Serum Levels of Toxin A Correlate with Disease Severity in Patients with Infection.感染患者血清中毒素A水平高与疾病严重程度相关。
Antibiotics (Basel). 2021 Sep 10;10(9):1093. doi: 10.3390/antibiotics10091093.
10
Mortality Following Infection in Europe: A Retrospective Multicenter Case-Control Study.欧洲感染后的死亡率：一项回顾性多中心病例对照研究。
Antibiotics (Basel). 2021 Mar 13;10(3):299. doi: 10.3390/antibiotics10030299.
Zotero 插件